Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Neven

Showing results (341-350 of 383) with videos related to

Pageof 39
Sort By:
JAMA Oncology|August 15, 2024
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast CancerRuth M O'Regan, Yi Zhang, Gini F Fleming, et al.
Breast (Edinburgh, Scotland)|December 12, 2025
Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapyAyelet Shai, Hans Wildiers, Claudio Venieri, et al.
Translational Oncology|September 13, 2019
Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute ParisLaurence Slembrouck, Lauren Darrigues, Cecile Laurent, et al.
NPJ Breast Cancer|February 20, 2026
Clinical and histopathological characterization of metastatic lobular breast cancer: lessons learned from post-mortem tissue donation programsGitte Zels, Karen Van Baelen, Alexander Cc Chang, et al.
Nature Communications|June 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world studyDavide Massa, Theodoros Foukakis, Sylvie Giacchetti, et al.
Nature|January 1, 2025
Aspartate signalling drives lung metastasis via alternative translationGinevra Doglioni, Juan Fernández-García, Sebastian Igelmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2024
Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER StudyKomal L Jhaveri, Elgene Lim, Rinath Jeselsohn, et al.
NPJ Breast Cancer|April 24, 2024
Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation programTatjana Geukens, Maxim De Schepper, Wouter Van Den Bogaert, et al.
JAMA Oncology|December 18, 2025
Enhancing Clinical Cancer Research Through Sharing of Data and BiospecimensHans Wildiers, Virginie Adam, Seamus O'Reilly, et al.
Nature Communications|July 21, 2023
Obesity-associated changes in molecular biology of primary breast cancerHa-Linh Nguyen, Tatjana Geukens, Marion Maetens, et al.
Pageof 39

Showing results (341-350 of 383) with videos related to

Sort By:
Pageof 39
JAMA Oncology|August 15, 2024
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast CancerRuth M O'Regan, Yi Zhang, Gini F Fleming, et al.
Breast (Edinburgh, Scotland)|December 12, 2025
Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapyAyelet Shai, Hans Wildiers, Claudio Venieri, et al.
Translational Oncology|September 13, 2019
Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute ParisLaurence Slembrouck, Lauren Darrigues, Cecile Laurent, et al.
NPJ Breast Cancer|February 20, 2026
Clinical and histopathological characterization of metastatic lobular breast cancer: lessons learned from post-mortem tissue donation programsGitte Zels, Karen Van Baelen, Alexander Cc Chang, et al.
Nature Communications|June 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world studyDavide Massa, Theodoros Foukakis, Sylvie Giacchetti, et al.
Nature|January 1, 2025
Aspartate signalling drives lung metastasis via alternative translationGinevra Doglioni, Juan Fernández-García, Sebastian Igelmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2024
Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER StudyKomal L Jhaveri, Elgene Lim, Rinath Jeselsohn, et al.
NPJ Breast Cancer|April 24, 2024
Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation programTatjana Geukens, Maxim De Schepper, Wouter Van Den Bogaert, et al.
JAMA Oncology|December 18, 2025
Enhancing Clinical Cancer Research Through Sharing of Data and BiospecimensHans Wildiers, Virginie Adam, Seamus O'Reilly, et al.
Nature Communications|July 21, 2023
Obesity-associated changes in molecular biology of primary breast cancerHa-Linh Nguyen, Tatjana Geukens, Marion Maetens, et al.
Pageof 39